Found: 70
Select item for more details and to access through your institution.
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1559, doi. 10.1007/s10637-021-01107-4
- By:
- Publication type:
- Article
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1036, doi. 10.1007/s10637-020-01055-5
- By:
- Publication type:
- Article
Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 468, doi. 10.1007/s10637-019-00787-3
- By:
- Publication type:
- Article
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells.
- Published in:
- Scientific Reports, 2016, p. 19772, doi. 10.1038/srep19772
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 6, p. i, doi. 10.1111/ejh.13344
- By:
- Publication type:
- Article
Association of CD204<sup>+</sup> macrophages with poor outcomes of malignant lymphomas not in remission treated by allogeneic HCT.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 6, p. 578, doi. 10.1111/ejh.13324
- By:
- Publication type:
- Article
Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors.
- Published in:
- Endocrinology, 2024, v. 165, n. 4, p. 1, doi. 10.1210/endocr/bqae016
- By:
- Publication type:
- Article
Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.681997
- By:
- Publication type:
- Article
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.564714
- By:
- Publication type:
- Article
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 463, doi. 10.1007/s11060-022-04165-7
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00239
- By:
- Publication type:
- Article
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 330, doi. 10.1002/jvc2.119
- By:
- Publication type:
- Article
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma.
- Published in:
- Oncology Letters, 2021, v. 21, n. 3, p. N.PAG, doi. 10.3892/ol.2021.12473
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer.
- Published in:
- Breast Cancer (13406868), 2020, v. 27, n. 4, p. 732, doi. 10.1007/s12282-020-01069-0
- By:
- Publication type:
- Article
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 1, p. 1, doi. 10.1007/s10147-023-02430-x
- By:
- Publication type:
- Article
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 4, p. 780, doi. 10.1007/s10147-017-1108-z
- By:
- Publication type:
- Article
Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 11, p. 2351, doi. 10.1007/s00432-017-2482-7
- By:
- Publication type:
- Article
Elevated Fibrin-Related Markers in Patients with Malignant Diseases Suspected of Having Thrombotic Disorders.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2010, v. 16, n. 3, p. 266, doi. 10.1177/1076029609340901
- By:
- Publication type:
- Article
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01606-7
- By:
- Publication type:
- Article
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01606-7
- By:
- Publication type:
- Article
High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 12, p. 4115, doi. 10.1245/s10434-016-5354-5
- By:
- Publication type:
- Article
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum to: Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2015
- By:
- Publication type:
- corrected article
Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Nephrotic syndrome with extensive mesangiolysis as a clinical manifestation of chronic graft-versus-host disease (GVHD).
- Published in:
- 2005
- By:
- Publication type:
- case study
Metabolic activity by F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 1, p. 56, doi. 10.1007/s00259-017-3806-1
- By:
- Publication type:
- Article
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03654-0
- By:
- Publication type:
- Article
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03629-1
- By:
- Publication type:
- Article
real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 623, doi. 10.1093/jjco/hyac024
- By:
- Publication type:
- Article
Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1232, doi. 10.1093/jjco/hyab064
- By:
- Publication type:
- Article
The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 693, doi. 10.1093/jjco/hyab013
- By:
- Publication type:
- Article
Troponin‐guided utilization of methylprednisolone pulse, intravenous immunoglobulin, and mycophenolate mofetil for successful control of immune checkpoint inhibitor–related myocarditis.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 6, p. e207, doi. 10.1111/1346-8138.17113
- By:
- Publication type:
- Article
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 6, p. 498, doi. 10.1111/1346-8138.14865
- By:
- Publication type:
- Article
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 6, p. 523, doi. 10.1007/s00280-022-04480-w
- By:
- Publication type:
- Article
Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Improved survival among patients enrolled in oncology phase 1 trials in recent decades.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13801-1
- By:
- Publication type:
- Article
Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11578-x
- By:
- Publication type:
- Article
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01900-4
- By:
- Publication type:
- Article